Receptor Proteins

TIE2 Identified as Drug Target in Brain Cavernous Malformations After Mouse Study Stops New Lesions

The preclinical findings point to a vessel‑focused approach that could reduce side effects compared with blocking the body‑wide PI3K pathway.